Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Protein Sciences develops emergency vaccine against Hong Kong influenza

Feb. 9, 1998

Cytel and Baxter extend xenotransplantation agreement

Feb. 5, 1998

CBER completes review of Thymoglobulin PLA

Feb. 2, 1998

OspC-based Lyme disease vaccine proves effective in animal model of chronic disease

Feb. 2, 1998

Aquila receives milestone payment from SKB under Stimulon agreement

Jan. 30, 1998

Another SMART antibody advances to clinical testing

Jan. 30, 1998

Positive U.S. phase II results for Thymoglobulin in preventing kidney transplant rejection

Jan. 28, 1998

Chesapeake Biological Laboratories and LXR to codevelop Cardiosol products

Jan. 27, 1998

Nabi's Altastaph enters phase I/II

Jan. 26, 1998

Quilimmune-P enters phase II

Jan. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...